RSR Limited

Active03766047 Private limited company

Incorporated: 7 May 1999 (27 years)
Industry: Manufacture of basic pharmaceutical products (21100)
Directors: Jenny Louise Boak
Janet Bradbury
Shu Chen
all 5 directors
Owned by: Dixondale Limited
Accounts type: Full
Address: 7 Robin Lane
High Bentham
Lancaster
LA2 7AB

Website & contact details

Website: rsrltd.com

Filing status

Accounts due: 30 June 2027
Last accounts: 30 September 2025
Conf. stmt due: 25 May 2027
Last conf. stmt: 11 May 2026

Officers 6 active

Officer details are public data from the Companies House register.

Boak, Jenny Louise

Director · Appointed 30 October 2025

Also at Dixondale Limited, AV7 Limited, Lotein Limited · more companies

British

Born November 1987

Boak, Jenny Louise

Secretary · Appointed 24 November 2023

Bradbury, Janet

Director · Appointed 23 August 2016

Also at Dixondale Limited, Lotein Limited, RSR Trustee Limited · more companies

British

Born October 1966 (60)

Chen, Shu, Dr

Director · Appointed 23 August 2016

Also at Dixondale Limited, AV7 Limited, Lotein Limited · more companies

British

Born August 1966 (60)

Sanders, Jane, Dr

Director · Appointed 23 August 2016

Also at Dixondale Limited, Lotein Limited, RSR Trustee Limited · more companies

British

Born November 1966

Rees Smith, Bernard, Dr

Director · Appointed 15 June 1999

Also at Dixondale Limited, Lotein Limited, RSR Trustee Limited · more companies

British

Born June 1944 (82)

Officer history (10 former)

30 October 2025

Appointed Boak, Jenny Louise as Director

24 November 2023

Appointed Boak, Jenny Louise as Secretary

24 November 2023

Resigned Carter, Lynn as Secretary

30 September 2022

Resigned Barwise, Jenny Louise as Secretary

30 September 2022

Appointed Carter, Lynn as Secretary

31 May 2022

Resigned Furmaniak, Jadwiga, Dr as Director

31 May 2022

Resigned Powell, Michael, Dr as Director

23 August 2016

Appointed Bradbury, Janet as Director

23 August 2016

Appointed Chen, Shu, Dr as Director

23 August 2016

Appointed Sanders, Jane, Dr as Director

23 August 2016

Appointed Furmaniak, Jadwiga, Dr as Director

23 August 2016

Appointed Powell, Michael, Dr as Director

25 July 2016

Appointed Barwise, Jenny Louise as Secretary

11 May 2016

Resigned Beck, Gillian as Secretary

11 May 2016

Resigned Beck, Gillian as Director

14 October 2009

Appointed Beck, Gillian as Director

24 July 2009

Resigned Rees-Smith, Jean as Director

31 July 2000

Resigned Rees Smith, Bernard, Dr as Secretary

31 July 2000

Appointed Beck, Gillian as Secretary

15 June 1999

Appointed Rees Smith, Bernard, Dr as Secretary

15 June 1999

Appointed Rees Smith, Bernard, Dr as Director

15 June 1999

Appointed Rees-Smith, Jean as Director

15 June 1999

Resigned Severnside Secretarial Limited as Corporate Nominee Secretary

15 June 1999

Resigned Severnside Nominees Limited as Corporate Nominee Director

7 May 1999

Appointed Severnside Secretarial Limited as Corporate Nominee Secretary

7 May 1999

Appointed Severnside Nominees Limited as Corporate Nominee Director

Ownership 1 active

People and entities with significant control, from the Companies House PSC register

Dixondale Limited

Corporate entity · Notified 30 April 2025

Owns 75–100% of shares

Holds 75–100% of voting rights

Right to appoint and remove directors

Limited By Shares

Reg. no. 01662593

Former controllers (1)

30 April 2025

Ceased Bernard Rees-Smith — Owns 75–100% of shares

Group structure 4 companies

Ownership group derived from the Companies House PSC register

Dixondale Limited

Lotein Limited Owns 75–100% of shares

RSR Limited This company Owns 75–100% of shares

AV7 Limited Owns 75–100% of shares

Financials

Figures from 2023 accounts. Newer accounts, made up to 30 September 2025, are filed but not read yet. See them on Companies House

Net Assets: £32,264,167
Cash: £19,608,167
Turnover: £22,176,065
Profit Before Tax: £19,491,069
Employees: 96

Debt Ratio: 3%
Current Ratio: 31.0x
Profit Margin: 88%
Return on Equity: 55%

Trend

Turnover

Balance sheet detail

	2023	2022	2021	2020	2019
Fixed Assets	£297,255	£409,357	£524,271	£583,711	£268,451
Current Assets	£33,063,411	£33,334,863	£23,770,049	£22,877,007	£23,276,785
Debtors	£11,814,506	£8,267,381	£9,106,057	£7,560,647	£7,792,089
Cash	£19,608,167	£23,280,723	£13,508,776	£14,066,279	£14,299,090
Creditors (< 1 year)	£1,066,930	£2,087,489	£609,179	£878,757	£1,974,338
Net Current Assets	£31,996,481	£31,247,374	£23,160,870	£21,998,250	£21,302,447
Net Assets	£32,264,167	£31,607,646	£23,617,545
Shareholder Funds	£32,264,167	£31,607,646	£23,617,545	£22,581,961	£21,570,898

Turnover	£22,176,065	£24,400,827	£21,507,203	£20,499,330	£21,023,482
Cost of Sales	£9,975,920	£6,349,046	£8,787,517	£7,667,812	£6,152,308
Gross Profit	£12,200,145	£18,051,781	£12,719,686	£12,831,518	£14,871,174
Admin Expenses	£3,435,176	£3,066,124	£3,143,364	£3,199,880	£3,414,812
Staff Costs	£6,084,980	£5,775,729	£5,570,084	£5,658,277	£5,738,932
Operating Profit	£19,437,701	£25,443,139	£17,783,376	£17,320,425	£19,853,959
Profit Before Tax	£19,491,069	£25,538,146	£17,804,194	£17,388,947	£19,903,625
Tax	£1,834,548	£3,548,045	£1,768,610	£1,377,884	£2,217,164
Profit for Period	£17,656,521	£21,990,101	£16,035,584	£16,011,063	£17,686,461

Filings 97

Date	Description	Made Up To
11 July 2026	Full accounts	30 September 2025
19 May 2026	Confirmation statement with no updates	11 May 2026
6 November 2025	Appointment of a director
6 November 2025	Secretary's details changed
6 October 2025	Full accounts	30 September 2024